Marché mondial du séquençage du génome entier au bisulfite (WGBS) – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse du marché et de la taille du séquençage du génome entier au bisulfite (WGBS)

Le séquençage du génome entier au bisulfite est une technologie de séquençage de nouvelle génération qui utilise le bisulfite de sodium pour déterminer l'état de méthylation de cytosines individuelles avant le séquençage de l'ADN à haut débit. L'état de méthylation de l'ADN au niveau de divers gènes peut révéler des informations sur la régulation des gènes et les activités transcriptionnelles.

Data Bridge Market Research analyse l’ensemble du marché du séquençage du génome au bisulfite (WGBS) qui devrait croître à un TCAC sain au cours de la période de prévision 2022 à 2029. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l’épidémiologie des patients, l’analyse du pipeline, l’analyse des prix et le cadre réglementaire.

Portée et segmentation du marché du séquençage du génome entier au bisulfite (WGBS)      

Définition du marché

Whole genome bisulfite sequencing (WGBS) is a critical technique in methylome research. Although a number of tools have been developed to address the mapping challenges caused by bisulfite treatment, the most recent tools available have not been evaluated in terms of read mapping performance as well as biological insights in multiple mammals.

Global Whole Genome Bisulfite Sequencing (WGBS) Market Dynamics

Drivers

• Rise in genome sequencing

Genome sequencing enables genome-wide methylation profiling at the single-base level which provides methylation status of every CpG locus including partial methylation domains, gene deserts, remote regulatory elements, others which reveals methylation sequence background and reveals absolute DNA methylation levels. During the forecast period of 2022–2029, these factors are boosting the growth of the whole genome bisulfite sequencing (WGBS) market.

• Rising applications of whole genome sequencing

Single nucleotide resolution methylation profiling at CG, CHG, and CHH sites. differentially methylated sites linked to experimental treatments or sample conditions, understanding cell differentiation or tissue development mechanisms using methylation profiles and early disease and cancer detection by detecting DNA hypermethylation or hypomethylation. These all are the applications of whole genome sequencing which boost the growth of the market.

Opportunities

• Rising advanced techniques

The increasing number of research and development activities, as well as the adoption of advanced techniques. For instance, whole genome bisulfite sequencing (WGBS) detects methylated cytosines by pre-sequencing the DNA with sodium bisulfite. WGBS has established itself as the gold standard for studying genome-wide methylation at single base resolution. These will provide various opportunities for the growth of the whole genome bisulfite sequencing (WGBS) market during the forecast period.

Restraints/Challenges

• Low coverage of whole genome bisulfite sequencing

The use of whole genome bisulfite sequencing has been hampered primarily by its high cost, complex data output, and low required coverage. Many studies using whole genome bisulfite sequencing assays have few or no biological replicates due to the high amount and subsequent cost of DNA input. Bisulfite converts unmethylated cytosines to thymidines, reducing sequence complexity, which can make it difficult to create alignments.

This whole genome bisulfite sequencing (WGBS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the whole genome bisulfite sequencing (WGBS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Whole Genome Bisulfite Sequencing (WGBS) Market Scope

The whole genome bisulfite sequencing (WGBS) market is segmented on the basis of product and services, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

• DNA Extraction
• DNA Fragmentation
• DNA Repair
• Adapter Ligation
• Bisulfite Treatment
• PCR Amplification

 Application

• Stem Cell Applications
• Developmental Biology
• Early Diagnosis of Diseases
• Forensic Science

 End User

• Pharmaceutical and Biotechnology Companies
• Academic and Government Institutes
• Contract Research Organizations

Whole Genome Bisulfite Sequencing (WGBS) Market Regional Analysis/Insights

The whole genome bisulfite sequencing (WGBS) market is analysed and market size insights and trends are provided by country, product and services, application and end user as referenced above.

The countries covered in the whole genome bisulfite sequencing (WGBS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the whole genome bisulfite sequencing (WGBS) market due to the surging levels of investment for the development of the healthcare industry along with growth of new technologies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing number of population suffering from diabetes.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché du séquençage du génome entier au bisulfite (WGBS)

Le paysage concurrentiel du marché du séquençage du génome entier au bisulfite (WGBS) fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du séquençage du génome entier au bisulfite (WGBS).

Certains des principaux acteurs opérant sur le marché du séquençage du génome entier au bisulfite (WGBS) sont :

• Illumina, Inc. (États-Unis)
• Epigentek Group Inc (États-Unis)
• CD Genomics (États-Unis)
• Thermo Fisher Scientific, Inc. (États-Unis)
• Novogene Co., Ltd. (Chine)
• PerkinElmer, Inc. (États-Unis)
• Promega Corporation (États-Unis)
• BGI (Chine)
• Nebula Genomics (États-Unis)
• Agilent Technologies (États-Unis)
• Qiagen (Allemagne)
• Macrogen Inc. (Corée du Sud)
• Oxford Nanopore Technologies plc. (Royaume-Uni)
• Veritas (États-Unis)

SKU-55716